26th Annual U.S. Psychiatric and Mental Health Congress 2013

528 views

Published on

Published in: Health & Medicine, Education
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
528
On SlideShare
0
From Embeds
0
Number of Embeds
11
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

26th Annual U.S. Psychiatric and Mental Health Congress 2013

  1. 1. 26TH ANNUAL 2013 ANNUAL PSY CH CONGR ESS THI N KING FORW A RD SCIENTIFIC PROGRAM C O M P L E T E S C H E D U L E REGISTER EARLY AND SAVE UP TO $400 September 30–October 3, 2013 THE VENETIAN, LAS VEGAS, NV 800-237-7285 EXT. 233 PSYCHCONGRESS.COM/PSYCHCONGRESS 90+ Exhibitors & Sponsors 50+ Exciting Sessions Up to 30 CME/CE Credits ®
  2. 2. REGISTER ONLINE! WWW.PSYCHCONGRESS.COM/PSYCHCONGRESS | 800-237-7285 EXT. 2332 Each year new research is being uncovered on mental health disorders. Treatment strategies are being changed to further improve outcomes and mental health professionals must stay up-to-date on advances in the field. Continuing medical education plays an essential role in the proper diagnosis and treatment of your patients. Get yours from the best. The U.S. Psychiatric and Mental Health Congress (Psych Congress) was established 26 years ago as an educational platform where experts in the mental health field could explore cutting-edge science, share comprehensive best practices and generate stimulating discussion. In 2013, Psych Congress is still thinking forward, providing attendees with advanced knowledge and unique tools from which they can confidently diagnose and develop effective individualized treatment plans, by applying evidence-based management into daily practice. Psych Congress is the nation’s largest independent educational conference for psychiatrists, primary care physicians, psychiatric nurses, psychologists, and other health care profession- als who seek to increase their knowledge, confidence and abilities to improve patient outcomes pertaining to mental health disorders. Nothing beats the attendee/expert interaction you will find at the 2013 Psych Congress. The myriad of unique, topical educational sessions combined with dynamic speakers and invalu- able networking opportunities simply can’t be found anywhere else. THE FIELD OF MENTAL HEALTH CONTINUES TO EVOLVE AT LIGHTNING SPEED. STAY AHEAD OF THE CURVE. ATTEND OUR CONFERENCE. PSYCH CONGRESS. ALWAYS THINKING FORWARD. UNIQUE EDUCATIONAL SESSIONS DYNAMIC SPEAKERS INVALUABLE NETWORKING POWERFUL TOOLS FOR PSYCH PROFESSIONALS 26TH ANNUAL 2013 U.S. Psychiatric and Mental Health Congress…    Psych Congress Network Building upon the powerful evidence- based, clinically relevant educational content featured at the annual conference, the U.S. Psychiatric and Mental Health Congress is now part of a larger mental health resource: Psych Congress Network. Psych Congress Network’s mission is to provide year-round psych information in a vibrant peer-to-peer community through its online presence, monthly e-newsletters, psych-related CME activities and national and regional meetings. Visit www.psychcongress.com to access the full experience. ® #psychcongress
  3. 3. Steering Committee and Faculty  Scientific Program  Exhibit Hall  Poster Pavilion  Meet the Experts  Hotel & Travel  Registration  GENERAL SCHEDULE TABLE OF CONTENTS,   2:30 p.m.–4:00 p.m. Educational Session 4:30 p.m.–7:00 p.m. Kick-Off Keynote Address: Eric Arauz (Non-CME) Dinner will be served. (limited seating – Pre-registration is required.) ,   7:00 a.m.–8:00 a.m. Welcome 8:00 a.m.–8:30 a.m. Continental Breakfast 8:00 a.m.–10:00 a.m. Industry Supported Symposia (CME) Breakfast will be served. (limited seating) 8:30 a.m.–11:45 a.m. Educational Sessions 12:00 p.m.–12:30 p.m. Lunch Break (Lunch on own) 12:00 p.m.–2:00 p.m. Industry Supported Symposia (CME) Lunch will be served. (limited seating) 12:30 p.m.–5:30 p.m. Educational Sessions 6:00 p.m.–7:30 p.m. Grand Opening of Exhibits/Reception ,   8:00 a.m.–10:00 a.m. Industry Supported Symposia (CME) Breakfast will be served. (limited seating) 8:00 a.m.–8:30 a.m. Continental Breakfast 8:30 a.m.–11:45 a.m. Educational Sessions 11:00 a.m.–4:00 p.m. Exhibit Hall, Meet the Experts, and Poster Pavilion 12:00 p.m.–12:30 p.m. Lunch Break (Lunch available for purchase in exhibit hall) 12:00 p.m.–1:30 p.m. Professional Medical Education Presentations (Non-CME) Lunch will be served. (limited seating) 4:00 p.m.–7:15 p.m. Educational Sessions ,   8:00 a.m.–10:00 a.m. Industry Supported Symposia (CME) Breakfast will be served. (limited seating) 8:00 a.m.–8:30 a.m. Continental Breakfast 8:30 a.m.–11:45 a.m. Educational Sessions 11:00 a.m.–2:00 p.m. Exhibit Hall, Meet the Experts, and Poster Pavilion 12:00 p.m.–12:30 p.m. Lunch Break (Lunch available for purchase in exhibit hall) 12:00 p.m.–1:30 p.m. Professional Medical Education Presentations (Non-CME) Lunch will be served. (limited seating) 2:00 p.m.–7:15 p.m. Educational Sessions ,   8:00 a.m.–10:00 a.m. Industry Supported Symposia (CME) Breakfast will be served. (limited seating) 8:00 a.m.–8:30 a.m. Continental Breakfast 8:30 a.m.–11:45 a.m. Educational Sessions 12:00 p.m.–12:30 p.m. Lunch Break (Lunch on own) 12:00 p.m.–2:00 p.m. Industry Supported Symposia (CME) Lunch will be served. (limited seating) 12:30 p.m.–5:30 p.m. Educational Sessions SPONSOR AND EDUCATION PROVIDER Naccme, LLC  Rike Drive, Suite A Millstone Township, NJ  : -- : -- www.naccme.com Pre-Conference LOGISTICS AND MEETING PROVIDER hmp communications, LLC  General Warren Blvd., Suite  Malvern, PA  -: -- : -- : -- www.hmpcommunications.com LLC, TM
  4. 4. PRE-CONFERENCE KICK-OFF KEYNOTE ADDRESS+TREATING THE WHOLE PATIENT Since most of our attendees traditionally arrive a day early to Psych Congress, we felt it fitting to offer up more opportunities to learn, share and network—at no additional cost. Be sure to check out the unprecedented programming we have lined up for Sunday, September 29 (see page 8) that includes a Treating the Whole Patient session (CME) that you won’t want to miss and our dynamic Kick-Off Keynote Address from Eric Arauz (Non-CME). Dinner will be served. Pre-registration is required as seating is limited. See registration page for details. NEW CHARITABLE PARTNERSHIP Psych Congress is pleased to announce our 2013 charitable partnership with Give an Hour, a ground- breaking non-profit organization that connects civilian clinicians with veterans afflicted with mental illness. Give an Hour was founded as a means to mobilize and coordinate a nationwide network, now comprised of over 7,000 mental health professionals, to assist veterans and service members, their families and communities who are in need of support. Make time to meet with the team from Give an Hour in the exhibit hall and learn how you can support this amazing cause. EMERGING CLINICIAN ABSTRACT COMPETITION Residents and fellows are an important part of our industry’s future. We are pleased to offer the Emerging Clinicians Abstract Competition as part of the 2013 Psych Congress program as a way to highlight some of the best and the brightest new voices in mental health. The Emerging Clinicians Abstract Competition allows residents and fellows to submit their work, either in research or case studies, to a panel of notable mental health professionals. For more details visit www.psychcongress.com/ psychcongress. FOR 2013 2013 KICK-OFF KEYNOTE ADDRESS 26TH ANNUAL 2013 ANNUAL PSY CH CONGR ESS THI N KING FORW A RD September 30–October 3, 2013 THE VENETIAN, LAS VEGAS, NV EMERGING CLINICIANAbstract Competition 2013 ™
  5. 5. REGISTER EARLY AND SAVE! CALL 800-237-7285 EXT. 233 | WWW.PSYCHCONGRESS.COM/PSYCHCONGRESS 5 WHO SHOULD ATTEND? Psych Congress is designed for psychiatrists, primary care physicians, psychologists, physician assistants, psychiatric nurses, nurse practitioners and other health care professionals who seek to improve the care of patients with mental health disorders and the outcomes resulting from that care. Learning Objectives After completing this educational program, partici- pants should be able to do the following: Identify the etiology, pathophysiology, and neural pathways of various psychiatric disorders and their effects on patients. Increase ability to assess psychiatric disorders as well as patients’ overall health, including comorbidities, with the goal of improving diagnosis and treatment. Implement evidence-based models on the use of psychotherapeutic and pharmacotherapeutic interven- tions to develop treatment plans, predict treatment response, optimize remission, and prevent relapse. Employ strategies to identify and remove barriers to treatment in order to improve patient outcomes in the acute and long-term management of psychi- atric disorders. ACCREDITATION INFORMATION In support of improving patient care, North Amer- ican Center for Continuing Medical Education, LLC (NACCME), is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Ac- creditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team. CME NACCME designates this live activity for a maximum of 30 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. CNE This continuing nursing education activity awards 30.0 contact hours. Provider approved by the California Board of Regis- tered Nursing, Provider #13255 for 30.0 contact hours. APA North American Center for Continuing Medical Edu- cation, LLC (NACCME) is approved by the American Psychological Association to sponsor continuing education for psychologists. NACCME maintains responsibility for this program and its content. Instructional Level Advanced REQUIREMENTS FOR CREDIT To be eligible for documentation of credit, participants must attend the educational activity and complete the evaluation form. After successful completion of the evaluation form online, participants may print their documentation of credit. Physician assistants, nurse practitioners and nurses may participate in this educational activity and earn a certificate of completion as AAPA, AANP and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements. Other health care professionals treating patients with mental health disorders should check with their state licensing and certification boards to determine if Psych Congress meets their continuing education requirements. HARDWARE/SOFTWARE REQUIREMENTS All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the fol- lowing browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com PSYCH CONGRESS 1 DAY REGIONAL MEETINGS Participants who have successfully completed educa- tional activities at the Psych Congress 1 Day Regional Meetings held at the Hyatt Regency O’Hare on June 22, 2013 and Hilton Philadelphia City Avenue on September 7, 2013 are not eligible to receive credit for these activities at the 2013 Psych Congress. ADA Statement North American Center for Continuing Medical Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educa- tionalactivityisinneedofaccommodations,pleasecall 609-371-1137. CONTACT INFORMATION For questions regarding this educational activity, please call 609-630-6252. DISCLOSURE It is the policy of NACCME, LLC to ensure balance, independence, objectivity and scientific rigor in all sponsored or jointly sponsored educational activities. Any individual in a position to control the content of an educational activity, including course or ac- tivity director, planners, advisory board members, staff, teachers or authors of CME, must disclose all relevant financial relationships as those in any amount occurring within the past 12 months that create a conflict of interest. Individuals who refuse to disclose will be disqualified from participation in the development, management, presentation and evaluation of the CME/CE activity. TERMS AND CONDITIONS Allinformationregardingsessions,symposia,speakers, topics, events, dates, and times is preliminary and subject to change up to and during the 2013 Psych Congress. The total credits that will be available are not guaranteed and are subject to change as circumstances require. Attendees are responsible for checking with their state licensing and certification boards to determine if the 2013 Psych Congress meets their continuing education requirements. All updated information will be reflected at www.psychcongress. com/psychcongress as it becomes available. The meeting organizer is not liable for any travel-related penalties, fees, losses, forfeitures, or related damages in the event the meeting is rescheduled or cancelled. PRIVACY POLICY NACCME protects the privacy of personal and other in- formationregardingparticipants,educationalpartners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information Copyright © 2013 by North American Center for Continuing Medical Education, LLC, an HMP Commu- nications Holdings Company. All rights reserved. No part of this accredited continuing medical education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from NACCME, LLC.
  6. 6. REGISTER ONLINE! WWW.PSYCHCONGRESS.COM/PSYCHCONGRESS6 26TH ANNUAL 2013 ANNUAL PSY CH CONGR ESS THI N KING FORWA RD 2013 PSYCH CONGRESS STEERING COMMITTEE Scott T. Aaronson, MD Director, Clinical Research Programs, Sheppard Pratt Health System, Baltimore, MD; Director, TMS Services, Sheppard Pratt Health System, Baltimore, MD Marc E. Agronin, MD Affiliate Associate Professor of Psychiatry and Neurology, University of Miami Miller School of Medicine, Miami, FL; Medical Director for Mental Health and Clinical Research, Miami Jewish Health Systems, Miami, FL Evelyn Attia, MD Professor of Psychiatry, Columbia University Medical Center, Weill Cornell Medical College, New York, NY; Director, Center for Eating Disorders, New York Presbyterian Hospital, The New York State Psychiatric Institute, New York, NY Alvin R. Blank, MD Medical Director, Cigna Behavioral Health, Lutherville, MD James Boehnlein, MD Professor of Psychiatry, Oregon Health and Science University (OHSU), Portland, OR; Associate Director for Education, VA Northwest Mental Illness Research, Education, and Clinical Center, Portland, OR; Staff Psychiatrist, Intercultural Psychiatric Program, OHSU, Portland, OR; Staff Psychiatrist, Portland VA Medical Center, Portland, OR Leslie Citrome, MD, MPH Clinical Professor of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY; Attending Physician, Good Samaritan Hospital, Suffern, NY Lori Daniels, PhD, LCSW Counselor, Portland Vet Center, Department of Veterans Affairs, Portland, OR Karl Doghramji, MD Professor of Psychiatry, Neurology, and Medicine; Medical Director, Jefferson Sleep Disorders Center, Philadelphia, PA; Program Director, Fellowship in Sleep Medicine, Thomas Jefferson University, Philadelphia, PA Vladimir Maletic, MD, MS 2013 PSYCH CONGRESS PROGRAM CHAIR Clinical Professor of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, SC; Consulting Associate, Division of Child and Adolescent Psychiatry, Department of Psychiatry, Duke University, Durham, NC Charles Raison, MD Associate Professor, Department of Psychiatry, University of Arizona College of Medicine; Barry and Janet Lang Associate Professor, John & Doris Norton School of Family and Consumer Sciences, College of Agriculture and Life Sciences, University of Arizona, Tucson, AZ; Mental Health Expert, Mind-Body Consultant for CNN.com; Scientific Vice-President, European Association of Clinical Psychoneuroimmunology Jon W. Draud, MS, MD Clinical Professor of Psychiatry, University of Tennessee College of Medicine, Memphis, TN; Medical Director of Psychiatry, Addiction, Medicine Services, Baptist Hospital, Nashville, TN; Middle Tennessee Medical Center, Murfreesboro, TN; Private Practice, Adult and Adolescent Psychiatry Saundra Jain, MA, PsyD, LPC Executive Director, Mental Aerobics Project, Lake Jackson, TX Andrew Penn, RN, MS, NP, CNS, APRN-BC Psychiatric Nurse Practitioner, Kaiser Permanente, Redwood City, CA; Assistant Clinical Professor, University of California, San Francisco Rakesh Jain, MD, MPH Associate Clinical Professor, Department of Psychiatry and Behavioral Sciences, University of Texas Medical School, Houston, TX; Director, Psychopharma- cology Research, R/D Clinical Research Center, Lake Jackson, TX  2013 PSYCH CONGRESS FACULTY
  7. 7. REGISTER EARLY AND SAVE! CALL 800-237-7285 EXT. 233 7 26TH ANNUAL 2013 ANNUAL PSY CH CONGR ESS THI N KING FORW A RD Craig L. Donnelly, MD Professor of Psychiatry & Pediatrics, Geisel Medical School at Dartmouth, Lebanon, NH; Chief, Section of Child & Adolescent Psychiatry, Dartmouth- Hitchcock Medical Center/CHaD, Lebanon, NH Timothy Fong, MD Director, UCLA Gambling Studies Program, Los Angeles, CA; Associate Professor of Psychiatry, University of California–Los Angeles, Los Angeles, CA Marlene P. Freeman, MD Associate Professor of Psychiatry, Harvard Medical School, Boston, MA; Director of Clinical Services, Perinatal and Reproductive Psychiatry, Massachusetts General Hospital, Boston, MA Doris Greenberg, MD Associate Clinical Professor of Pediatrics, Mercer University School of Medicine, Savannah, GA; Developmental and Behavioral Pediatrician, Memorial University Medical Center, Pediatric Residency Program, Savannah, GA Ronald E. Hellman, MD, MS, FAPA Director, LGBT Affirmative Program, South Beach Psychiatric Center, Brooklyn, NY Robert L. Hendren, DO Professor and Vice Chair, Director of Child and Adolescent Psychiatry, University of California– San Francisco, San Francisco, CA Dilip V. Jeste, MD Estelle and Edgar Levi Chair in Aging, Director, Sam and Rose Stein Institute for Research on Aging, Distinguished Professor of Psychiatry & Neurosciences, Director of Education, Clinical and Translational Research Institute, University of California–San Diego, San Diego, CA; Past-President, American Psychiatric Association Daniel Krashin, MD Acting Assistant Professor, Departments of Psychiatry, Pain & Anesthesia, University of Washington, Seattle, WA; Attending Physician, Harborside Medical Center, University of Washington, Seattle, WA Stuart Lustig, MD, MPH Regional Medical Director, Cigna Behavioral Health, Glendale, CA; Adjunct Associate Professor, Department of Psychiatry, University of California–San Francisco, School of Medicine, San Francisco, CA Bill McCarberg, MD Adjunct Assistant Clinical Professor, University of California–San Diego, San Diego, CA; Physician, Neighborhood Healthcare, Escondido, CA Natalia Murinova, MD Assistant Clinical Professor, University of Seattle, Seattle, WA; Attending Physician, Neurology Headache Clinic, Seattle, WA Douglas L. Noordsy, MD Associate Professor of Psychiatry, Geisel School of Medicine at Dartmouth, Lebanon, NH; Director of Psychosis Services, Dartmouth Hitchcock Medical Center, Lebanon, NH Christine A. Padesky, PhD Co-Founder and Director, Center for Cognitive Therapy, Huntington Beach, CA Darrel A. Regier, MD, MPH Director, Division of Research, Vice-Chair, DSM-5 Task Force, American Psychiatric Association, Arlington, VA; Clinical Professor, Georgetown University School of Medicine, Washington, DC Phillip Resnick, MD Professor of Psychiatry, Case Western Reserve University, Cleveland, OH; Director of Forensic Psychiatry, University Hospitals Case Medical Center, Cleveland, OH Kerry J. Ressler, MD, PhD Professor of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA Judith Rice, DNP, PMHNP-BC, FNP-BC Assistant Professor, East Tennessee State University, Johnson City, TN; Johnson City Community Health Center, Johnson City, TN Benjamin J. Sadock, MD Gregory S. Menas Professor of Psychiatry, NYU School of Medicine, New York, NY Gerard Sanacora, MD, PhD Professor, Yale Univesity, School of Medicine, New Haven, CT; Director, Yale Depression Research Program, Ribicoff Research Facilities CMHC, New Haven, CT S. Charles Schulz, MD Professor and Head, Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN; University of Minnesota Physicians, Minneapolis, MN Kenneth R. Silk, MD Professor of Psychiatry, University of Michigan Medical School, Ann Arbor, MI; Director, Personality Disorders Program, University of Michigan Health System, Ann Arbor, MI Vivek Singh, MD Associate Professor, University of Texas Health Science Center at San Antonio, San Antonio, TX; UT Medicine – Psychiatry, San Antonio, TX Stephen V. Sobel, MD Clinical Instructor, University of California–San Diego, School of Medicine, San Diego, CA; Consulting Psychiatrist, NFL San Diego Chargers, San Diego, CA; Private Practice, Adult and Adolescent Psychiatry, San Diego, CA Linda Stanley, PMHNP, MSHS, BSN Psychiatric Nurse Practitioner, University of San Diego, San Diego, CA Rajiv Tandon, MD Professor of Psychiatry, University of Florida College of Medicine, Gainesville, FL; Chief, Psychiatry Service, North Florida/South Georgia Veterans Health Systems, Gainesville, FL Timothy E. Wilens, MD Associate Professor of Psychiatry, Harvard Medical School, Boston, MA; Clinical Director, Center for Addiction Medicine, Massachusetts General Hospital, Boston, MA Mark Zimmerman, MD Professor of Psychiatry and Human Behavior, Brown Medical School, Providence, RI; Director of Outpatient Psychiatry, Rhode Island Hospital, Providence, RI September 30–October 3, 2013 | The Venetian, Las Vegas, NV
  8. 8. REGISTER ONLINE! WWW.PSYCHCONGRESS.COM/PSYCHCONGRESS8 26TH ANNUAL 2013 ANNUAL PSY CH CONGR ESS THI N KING FORWA RD Scientific Program | SUNDAY, SEPTEMBER 29, 2013 *NOTE: as of May 1, 2013; sessions and schedule subject to change without notice. 2013 Scientific Program Overview The 2013 Psych Congress Scientific Program details sessions that keep mental health care professionals up-to-date on evidence- based clinical and scientific advances and thinking forward in applying knowledge and tools that can be immediately applied in daily practice to improve patient outcomes and care. The program covers a broad spectrum of topics and educational formats, providing more than 50 sessions to choose from. 4:30 P.M.– 7:00 P.M. KICK-OFF KEYNOTE ADDRESS & DINNER RECEPTION (NON-CME) Seating is limited – Pre-registration is required. Please check your registration confirmation to confirm your seat. “ ” with Eric Arauz How much can one person endure? Child abuse at the hands of a mentally-ill father, bipolar 1 disorder, PTSD (from trauma that occurred during psychiatric hospitalization), alcohol and drug addiction, being told you are beyond treatment. Our 2013 Kick-Off Keynote Speaker, Eric Arauz, will share these experiences and explain how he overcame the demons to live a fulfilling life as an academic, author, orator, mental health advocate and father. Join us for a very special evening featuring a cocktail reception, keynote address, and seated dinner — and leave inspired and empowered by Eric’s experiences. Seating is limited. RSVP required through registration. All attendees will receive a copy of Eric’s new book, An American’s Resurrection. SUNDAY, SEPTEMBER 29, 2013 2:30 P.M.– 4:00 P.M. TREATING THE WHOLE PATIENT Beyond the Syndrome: Advances in the Integrated Science of Mood Disorders limited seating Treating the Whole Patient encourages health care professionals to adopt a multidimensional approach that explores the relationship between mental health and physical conditions. Based on cutting-edge scientific data in fields as diverse as neuroscience, genetics and immunology, Treating the Whole Patient demonstrates how integrated mind-body perspectives can optimize therapeutic outcomes regarding psychiatric illness. : Treating the Whole Patient : Jon W. Draud, MS, MD; Rakesh Jain, MD, MPH; Vladimir Maletic, MD, MS; Charles Raison, MD PRE-CONFERENCE
  9. 9. REGISTER EARLY AND SAVE! CALL 800-237-7285 EXT. 233 9 Scientific Program | 26TH ANNUAL 2013 ANNUAL PSY CH CONGR ESS THI N KING FORW A RD MONDAY, SEPTEMBER 30, 2013 8:00 A.M.–10:00 A.M. Industry Supported Symposia (CME) Breakfast will be served at 8:00 a.m. Limited Seating 8:30 A.M.–10:00 A.M. Autism Update: Etiology, Assessment, and Treatment The session will take the participant through the rapid growth in good clinical research related to autism spectrum disorders. Ranging from utilizing the new DSM-5 classification system to appreciating the clinical implications of the complex gene by environment interaction research, the session will also bring the participant up-to-date on ordering and interpreting biomedical assessments and ensuring their patients are receiving the most comprehensive, evidence-based treatments. : Autism Spectrum/Developmental Disorders, Neurology/Neuroscience : Robert L. Hendren, DO 10:15 A.M.–11:45 A.M. FEATURED SESSION DSM-5 Overview: What Clinicians Need to Know and Practical Applications The goal of the session is to educate mental health professionals on the most significant revisions to DSM-5 that are likely to impact clinical performance. General use of the manual will also be covered, including DSM-5’s dimensional approach to diagnosis, issues pertinent to ICD-9-CM and ICD-10-CM coding, forensic considerations and orientation to the non- axial format. : DSM-5 : Darrel A. Regier, MD, MPH FEATURED SESSIONS give participants the opportunity to maximize their Psych Congress educational experience by being able to select one of two timeslots for popular presentations. Credit may only be claimed once for these sessions. MONDAY, SEPTEMBER 30, 2013 FS    Considered one of the best pure orators in the United States, Eric Arauz is lead trainer and international keynote speaker through his consulting firm, A.I.E., specializing in trauma/, suicide, child abuse, addiction and veterans issues. Having suffered extensive child abuse at the hands of a father with mental illness, along with his own institutionalization in , Eric speaks openly about his personal “triumph over the demons of substance abuse, child abuse, psychosis, and posttraumatic stress disorder” and how the mental health community can better serve their patients. Eric holds a BA in American Studies from Rutgers University with high honors and a Masters Degree from the Rutgers Graduate School of Management of Labor Relations. He is an adjunct instructor in the Department of Psychiatry at /Robert Wood Johnson Medical School, a Special State Officer on the New Jersey Governor's Council on Alcoholism and Drug Abuse, a  /US Department of Health and Human Services "Voice Award" recipient, and New York Times contributor. In , Eric published his first book, An American’s Resurrection.     ’  
  10. 10. REGISTER ONLINE! WWW.PSYCHCONGRESS.COM/PSYCHCONGRESS10 26TH ANNUAL 2013 ANNUAL PSY CH CONGR ESS THI N KING FORWA RD Scientific Program | Beyond GABA: Novel Mechanisms in the Management of Insomnia Although numerous hypnotic agents are available for its management, their mechanisms of action are largely identical (ie, activation at the GABA-BZ receptor complex). Over the past few years, however, a variety of agents with novel mechanisms have been introduced for insomnia management. A variety of such medications are also under development. Mental health professionals have, traditionally, utilized various medications to treat insomnia that are not indicated for that purpose, but which have complex, non-GABAergic receptor profiles. The session reviews basic sleep mechanisms and the role of traditional GABAergic medications in the generation of sleep states. It also provides an update of the array of non-GABAergic agents, many of which represent older agents with other indications, and others that are either specifically indicated for insomnia or under development for that purpose. The session clarifies how these novel agents fit into the CNS mechanisms responsible for sleep initiation and maintenance. : Sleep Disorders, Psychopharmacology : Karl Doghramji, MD Bringing Accountability to Office-Based Treatment of Depression The session introduces clinicians to the concept of measurement-based care in the treatment of depression, and educates them as to why this approach towards management is likely to be more widely adopted in the future. Participants will be informed about tools that can be incorporated into clinical practice to improve the efficiency and accuracy of measuring outcome in the treatment of depression. : Mood Disorders, Practice Management : Mark Zimmerman, MD 12:00 P.M.–2:00 P.M. Industry Supported Symposia (CME) Lunch will be served at 12:00 p.m. limited seating 12:30 P.M.–2:00 P.M. Premenstrual Dysphoric Disorder and Menopausal Depression Women are vulnerable to manifestations of psychiatric illness across the reproductive lifespan with specific patterns of illness related to times of hormonal variability. Premenstrual dysphoric disorder and other menstrual cycle-related mood disturbances are one example. The session discusses specific treatment considerations for the management of menstrual cycle-related mood dysregulation. The menopausal transition is a time of increased risk of new episode and recurrent depression. Treatment considerations for depression and other symptoms related to the menopausal transition will also be discussed. : Women’s Mental Health, Mood Disorders : Marlene P. Freeman, MD 2:15 P.M.–3:45 P.M. The Dementia Dilemma: Diagnosis and Treatment of Agitation and Psychosis The majority of individuals suffering from dementia demonstrate symptoms of agitation and psychosis at some point during the course of illness. The session reviews current thinking on the causes of these symptoms and the dilemmas surrounding treatment with both pharmacological and behavioral approaches. : Dementia & Cognitive Disorders,Geriatric Psychiatry : Marc E. Agronin, MD MONDAY, SEPTEMBER 30, 2013 “Psych Congress has been, by far, better than any other conference I’ve attended. Everyone around has had the same consensus — it’s a smooth running meeting, with terrific value. I’m going to attend for years to come!” — ARLINE K., MD MIAMI BEACH, FL
  11. 11. REGISTER EARLY AND SAVE! CALL 800-237-7285 EXT. 233 11 Scientific Program | 26TH ANNUAL 2013 ANNUAL PSY CH CONGR ESS THI N KING FORW A RD FEATURED SESSION DSM-5 Overview: What Clinicians Need to Know and Practical Applications The goal of the session is to educate mental health professionals on the most significant revisions to DSM-5 that are likely to impact clinical performance. General use of the manual will also be covered, including DSM-5’s dimensional approach to diagnosis, issues pertinent to ICD-9-CM and ICD-10-CM coding, forensic considerations and orientation to the non- axial format. : DSM-5 : Darrel A. Regier, MD, MPH FEATURED SESSIONS give participants the opportunity to maximize their Psych Congress educational experience by being able to select one of two timeslots for popular presentations. Credit may only be claimed once for these sessions. Mass Murder and Murder-Suicide Clinicians as well as the public at large are trying to make sense of recent mass shootings, particularly the Newtown, Connecticut tragedy. Many clinicians are not sufficiently confident in their ability to assess their own patients for their potential to commit multiple homicides. Participants will learn the characteristics and motives of mass murderers and persons who kill family members and themselves. The relationship between homicidality and suicidality will be elucidated. : Forensic Psychiatry, Harm to Self & Others : Phillip Resnick, MD 4:00 P.M.–5:30 P.M. Integrated Treatment for Borderline Personality Disorder: How to Utilize and Organize Intervention It is now better known through epidemiology study that borderline personality disorder (BPD) is present in nearly 5% of the population and that BPD patient services make up a significant amount of inpatient and outpatient services. The session reviews and discusses the coordinated approaches to BPD. It reviews and assesses the medication role in coordinated care. The session also reviews data-based psychosocial interventions and how to integrate care. : Personality Disorders : S. Charles Schulz, MD The Perils and Promise of Psychoactive Drugs: A Focus on Harm Reduction Psychiatry The relationship between psychopharmacology and drug abuse is increasingly complex. Recent studies have indicated that potentially abusable drugs, such as MDMA, may show significant promise for the treatment of post-traumatic stress disorder. Ketamine is being used successfully to treat severe depression. Many patients use cannabis and feel that it helps them. What is a practicing clinician to do? The session critically examines the claims for benefit of these and other substances, and examines both the biology of potential benefit and the potential risks of these substances. By emphasizing harm reduction and motivational interviewing techniques, clinicians will be better equipped to have nuanced and sophisticated conversations with their patients about drug use. : Substance Abuse, Addiction & Deterrence, Neurology/Neuroscience : Andrew Penn, RN, MS, NP, CNS, APRN-BC Taming the Beast: Practical and Effective Non-Pharmacological Treatment Options for Bipolar Depression Taking care of patients with bipolar depression is never an easy task for those of us charged with this responsibility. Pharmacological treatment is the foundation of taking care of this phase of bipolar disorder. However, many times medications alone are simply not enough. Clinicians often underappreciate and underutilize these non- pharmacological treatment options and the session aims to bridge this gap. The session reviews practical and effective non-pharmacological treatment options and a variety of tools and resources to assist in caring for these challenging patients. Augmenting pharmacological interventions with non-pharmacological treatment options leads to reduction in depression, reduction in relapses, and improvement in quality of life. : Mood Disorders : Saundra Jain, MA, PsyD, LPC 6:00 P.M.–7:30 P.M. GRAND OPENING OF EXHIBITS/RECEPTION LIGHT FARE AND BEVERAGES PROVIDED MONDAY, SEPTEMBER 30, 2013 FS
  12. 12. REGISTER ONLINE! WWW.PSYCHCONGRESS.COM/PSYCHCONGRESS12 26TH ANNUAL 2013 ANNUAL PSY CH CONGR ESS THI N KING FORWA RD Scientific Program | TUESDAY, OCTOBER 1, 2013 8:00 A.M.–10:00 A.M. Industry Supported Symposia (CME) Breakfast will be served at 8:00 a.m. limited seating 8:30 A.M.–10:00 A.M. Schizophrenia Circa 2013 and Beyond The concept of schizophrenia has evolved since its formulation over a century ago and our appreciation of its nature and clinical approach to the disorder has changed over this period. In this session, our current knowledge about the nature of schizophrenia will be summarized and limitations/critical gaps in our understanding will be enumerated. Research developments addressing these gaps will be considered and the likely future of this disorder will be discussed. : Schizophrenia : Rajiv Tandon, MD 10:15 A.M.–11:45 A.M. FEATURED SESSION Posttraumatic Stress Disorder: Recent Advances from Neurobiology to the Clinic Traumatic events that produce extreme fear and horror are common, but not all individuals develop posttraumatic stress disorder (PTSD) as a result of such exposure. What mediates risk and resilience in the development of stress-related psychopathology is a critical question. Biological factors, such as genotype and neurobiology, interact with environmental factors, such as childhood background and trauma load, to affect vulnerability and resilience in the aftermath of trauma exposure. A variety of new research that will be presented suggests that understanding mediators of synaptic plasticity across translational models of fear will further our understanding and potential therapeutic approaches to fear-related disorders in humans, such as PTSD. : Posttraumatic Stress Disorder : Kerry J. Ressler, MD, PhD FEATURED SESSIONS give participants the opportunity to maximize their Psych Congress educational experience by being able to select one of two timeslots for popular presentations. Credit may only be claimed once for these sessions. Diagnosis of Bipolar Disorder: Underdiagnosis, Overdiagnosis, and Why Screening Scales Are Not Good Enough The session educates clinicians as to the respective consequences of both underdiagnosis and overdiagnosis of bipolar disorder (BD). The decade-long emphasis on underdiagnosis has resulted in the recently recognized problem of overdiagnosis, with its attendant risks. The session highlights the conceptual and practical problems with the use of screening scales in clinical practice, and describes an alternative approach towards improving the validity of diagnosing BD in clinical practice. : Mood Disorders, Assessment & Adherence : Mark Zimmerman, MD Alzheimer’s Update 2013 As the geriatric population increases, most clinicians are seeing an explosion in cases of Alzheimer’s disease (AD). As our understanding of AD changes quickly and the pace of new treatment studies increases, it is critical for clinicians to be up-to-date on the latest approaches to diagnosis and treatment. The session provides a comprehensive update on the diagnosis and treatment of AD based on the latest developments and research studies. : Dementia & Cognitive Disorders, Geriatric Psychiatry : Marc E. Agronin, MD EXHIBIT HALL, MEET THE EXPERTS, AND POSTER PAVILION 11:00 A.M.–4:00 P.M. TUESDAY, OCTOBER 1, 2013 FS “Psych Congress attracts the best teachers and scholars in psychiatry who attack the greatest issues in the field through their experiences, their research, and their collaboration with attendees and other faculty members.” — LARRY R., MD LYNN HAVEN, FL
  13. 13. REGISTER EARLY AND SAVE! CALL 800-237-7285 EXT. 233 13 Scientific Program | 26TH ANNUAL 2013 ANNUAL PSY CH CONGR ESS THI N KING FORW A RD 12:00 P.M.–1:30 P.M. PME Professional Medical Education Presentations (Non-CME) Lunch will be served. (limited seating) Uncover the latest information, data, and research findings with disease-state or product-specific presentations. Ask questions of key experts and industry representatives, and assess the value to your patient care. Seating is limited and available on a first-come, first-served basis. Professional Medical Education (PME) presentations are not intended or eligible for CME credit. MEET THE EXPERTS 1:30 P.M.–2:00 P.M., 2:10 P.M.–2:40 P.M., 2:50 P.M.–3:20 P.M., 3:30 P.M.–4:00 P.M. 4:00 P.M.–5:30 P.M. Perinatal Mood Disorders The session will discuss perinatal mood disorders, including considerations for women with depression and bipolar disorder during pregnancy and postpartum. Presentation of illness, risks/benefits for treatment decisions, and pharmacologic treatment considerations for pregnancy and breastfeeding will be assessed. Postpartum psychosis will be discussed as well, including risk factors and treatment. Risks and benefits of treatment options and risks of untreated mood disorders will be included, as well as data regarding specific medications across the perinatal period. : Women’s Mental Health, Mood Disorders : Marlene P. Freeman, MD FEATURED SESSION Posttraumatic Stress Disorder: Recent Advances from Neurobiology to the Clinic Traumatic events that produce extreme fear and horror are common, but not all individuals develop posttraumatic stress disorder (PTSD) as a result of such exposure. What mediates risk and resilience in the development of stress-related psychopathology is a critical question. Biological factors, such as genotype and neurobiology, interact with environmental factors, such as childhood background and trauma load, to affect vulnerability and resilience in the aftermath of trauma exposure. A variety of new research that will be presented suggests that understanding mediators of synaptic plasticity across translational models of fear will further our understanding and potential therapeutic approaches to fear-related disorders in humans, such as PTSD. : Posttraumatic Stress Disorder : Kerry J. Ressler, MD, PhD FEATURED SESSIONS give participants the opportunity to maximize their Psych Congress educational experience by being able to select one of two timeslots for popular presentations. Credit may only be claimed once for these sessions. Neurostimulation for Mood Disorders Transcranial magnetic stimulation (TMS) is gaining increasing acceptance for the treatment of depression along with increasing insurance coverage. It is important that practicing clinicians understand where TMS fits in the psychiatric armamentarium and how it differs from other approved neurostimulation techniques, including electroconvulsive therapy and vagus nerve stimulation. The session provides an overview of the current and future neurostimulation environment. : Mood Disorders, Neuromodulation : Scott T. Aaronson, MD TUESDAY, OCTOBER 1, 2013 FS “There is high value in attending, and that’s what keeps me coming back year after year” — IVA T., MD PIPE CREEK, TX
  14. 14. REGISTER ONLINE! WWW.PSYCHCONGRESS.COM/PSYCHCONGRESS14 26TH ANNUAL 2013 ANNUAL PSY CH CONGR ESS THI N KING FORWA RD Scientific Program | 5:45 P.M.–7:15 P.M. Ending the Endless Struggle: The Keys to Effective Treatment of OCD Obsessive-compulsive disorder is an extremely common disorder that can devastate lives. Its treatment is tremendously challenging and involves the proper use of psychotropic medications and appropriate psychotherapy based upon an understanding of the biopsychosocial etiology. The session teaches participants the keys to the evidence-based selection of medications and the application of psychotherapy. : Anxiety Disorders : Stephen V. Sobel, MD When Daddy or Mommy Deploys: Children of Deployed Military Parents Many military families have suffered traumas secondary to the deployment of a parent and the family disruption that ensues. The session focuses on understanding the needs of the children and families during and after deployment as well as understanding the results of a parent being killed. : Child & Adolescent Psychiatry : Doris Greenberg, MD Beyond Medication Treatment of ADHD: Practical & Complementary Interventions The session provides participants who typically rely on medication as the primary treatment intervention in attention-deficit hyperactivity disorder (ADHD) with practical strategies for improving functional outcomes for children and families beyond the effects attainable with medication alone. Treatments that act synergistically with medication will be reviewed. The session focuses on the identification and selection of appropriate therapies, matching therapies to individual patient and family needs, and the specifics of parenting behavioral strategies, contingency management and interventions that span home and school settings. The emphasis will be on pragmatic and time efficient methods to monitor treatment response, initiate non-pharmacological treatments, and work collaboratively with primary care providers and psychotherapists to optimize outcomes in children with ADHD. Treatment strategies for children with ADHD and comorbid oppositional defiant disorder will be highlighted. : ADHD : Craig L. Donnelly, MD TUESDAY, OCTOBER 1, 2013 26TH ANNUAL 2013 Pre-ORDER YOUr 2013 COMPREHENSIVE SESSION SYLLABUS Choice of Printed or Electronic Format (PDF) Add to your cart when registering to guarantee that your syllabus will be waiting for you at check-in!
  15. 15. REGISTER EARLY AND SAVE! CALL 800-237-7285 EXT. 233 15 Scientific Program | 26TH ANNUAL 2013 ANNUAL PSY CH CONGR ESS THI N KING FORW A RD WEDNESDAY, OCTOBER 2, 2013 8:00 A.M.–10:00 A.M. Industry Supported Symposia (CME) Breakfast will be served at 8:00 a.m. limited seating 8:30 A.M.–10:00 A.M. Violence and Aggression: Managing the Acute Episode and Beyond The management of agitation requires two simultaneous approaches. First, there is a need to manage acute episodes of agitation. Second, there is a need to decrease the frequency and intensity of these episodes. New pharmacological approaches promise to quickly calm the agitated patient and treat the underlying disease process that may be the root cause for the disturbed behavior. : Harm to Self & Others, Psychopharmacology : Leslie Citrome, MD, MPH 10:15 A.M.–11:45 A.M. Psychotic Disorders in DSM-5 With the publication of DSM-5 in 2013, a number of significant changes in the diagnostic approach to psychotic disorders have been made. The session summarizes the nature and rationale behind these changes and discusses the implications of these changes for clinical practice. : Psychotic Disorders : Rajiv Tandon, MD Using Benzodiazepines: The Good, The Bad, and The Ugly How many of us are guilty of wanting a quick fix when it comes to nutrition, weight, fitness, and health? When it comes to mental health, the quick fix is often what patients want. Benzodiazepines are often the answer to the quick fix as they are effective and fast-acting. However, is there a price to be paid? How often have we seen benzodiazepine-related deaths in the news or heard our colleagues share a story of misuse or abuse? How do we as clinicians decide when and if using benzodiazepines is the correct clinical path? The session looks at both sides of this perplexing story so that we as clinicians can individually make up our minds about the potential benefits and the pitfalls of using these controversial medications. : Psychopharmacology : Rakesh Jain, MD, MPH; Saundra Jain, MA, PsyD, LPC New Developments in the Treatment of Major Depressive Disorder The last few years have seen a major expansion in the targets being pursued in the development of novel antidepressant treatments. A better critical understanding of the promise and limitations of these emerging therapeutics is essential to provide guidance to patients interested in pursuing novel and experimental treatments. The session familiarizes the participants with recent developments in the treatment of depression. It specifically focuses on the development of treatments with rapid onset of action and efficacy in treatment-resistant depression. : Mood Disorders, Psychopharmacology : Gerard Sanacora, MD, PhD EXHIBIT HALL, MEET THE EXPERTS, AND POSTER PAVILION 11:00 A.M.–2:00 P.M. 12:00 P.M.–1:30 P.M. PME Professional Medical Education Presentations (Non-CME) Lunch will be served. (limited seating) Uncover the latest information, data, and research findings with disease-state or product-specific presentations. Ask questions of key experts and industry representatives, and assess the value to your patient care. Seating is limited and available on a first-come, first-served basis. Professional Medical Education (PME) presentations are not intended or eligible for CME credit. MEET THE EXPERTS 1:30 P.M.–2:00 P.M. WEDNESDAY, OCTOBER 2, 2013
  16. 16. REGISTER ONLINE! WWW.PSYCHCONGRESS.COM/PSYCHCONGRESS16 26TH ANNUAL 2013 ANNUAL PSY CH CONGR ESS THI N KING FORWA RD Scientific Program | 2:15 P.M.–3:45 P.M. Prescription for Panic: Cognitive-Behavioral Therapy According to American Psychiatric Association practice guidelines, pharmacotherapy and cognitive-behavioral therapy (CBT) are both first-line recommended treatments for panic disorder. When length of treatment and relapse are considered, CBT has been shown in numerous randomized controlled outcome studies to be superior to pharmacological treatments. Yet many mental health professionals lack the knowledge and skill to either competently deliver CBT for panic disorder or describe it well enough to patients to facilitate a successful referral. The session describes and provides video demonstrations of each of the essential stages of effective CBT for panic disorder. With characteristic clarity, warmth, and humor, Dr. Padesky makes the case for why CBT should usually be the first “prescription for panic.” : Psychotherapy, Anxiety Disorders : Christine A. Padesky, PhD Eating Disorders: An Update and Introduction to DSM-5 Eating disorders are complex psychiatric conditions that commonly involve physiological as well as psychological manifestations. Individuals affected with these disorders may be reluctant to discuss their symptoms with mental health providers. The session reviews the diagnosis, epidemiology, and treatment of eating disorders, including anorexia nervosa, bulimia nervosa, and binge eating disorder. Recent changes to these diagnoses made for DSM-5 will be described. : Eating Disorders : Evelyn Attia, MD Telepsychiatry Applications in Child Psychiatry: Creating Systems of Collaborative Care The session addresses several of the important barriers that limit access for children and families to expert child and adolescent psychiatric care and how these barriers may be overcome by cost-wise, strategic and efficient applications of telepsychiatry. Using rural New Hampshire as an example, the session focuses on the creation of networks of collaborative care using telepsychiatry to improve access to care in highly underserved regions of the state for high risk children and families. The session describes building systems of care using a telepsychiatry- based “Consultation-Education-Collaboration” model involving partnerships between primary care practitioners, community mental health, an academic medical center, and allied mental health professionals. Description of the model’s cost efficiency, scalability and its capacity to amplify scarce child psychiatry resources into high need regions is presented in sufficient detail to allow transportability into other areas facing similar barriers to care. : Child & Adolescent Psychiatry : Craig L. Donnelly, MD 4:00 P.M.–5:30 P.M. Combination Therapy in Bipolar Disorder The session aims to elucidate the reasons and rationale for combined therapy in bipolar illness. The session discusses evidence-based combination regimens in bipolar disorder (BD) in various mood states of BD. Risks associated with combination therapy will also be discussed. : Mood Disorders, Psychopharmacology : Vivek Singh, MD Antipsychotics: What’s New? What’s Different? What’s Next? The session will provide an up-to-date review of new antipsychotic medications and/or formulations that have become available within the past few years. The backdrop to the discussion will be the framework of evidence- based medicine using tools such as number needed to treat (NNT) and number needed to harm (NNH). There remains a need for further discussion of the concept of effectiveness as a driver for medication selection, taking into account efficacy, tolerability, and patient adherence. The session will review the three new oral second-generation antipsychotics (iloperidone, asenapine, and lurasidone), the two new depot second-generation antipsychotics (olanzapine pamoate and paliperidone palmitate), and two agents in late-stage development (inhaled loxapine and depot aripiprazole). : Schizophrenia, Psychopharmacology : Leslie Citrome, MD, MPH WEDNESDAY, OCTOBER 2, 2013
  17. 17. REGISTER EARLY AND SAVE! CALL 800-237-7285 EXT. 233 17 Scientific Program | 26TH ANNUAL 2013 ANNUAL PSY CH CONGR ESS THI N KING FORW A RD When Your Patient Dies by Suicide: Aftermath and Implications Over 50% of mental health professionals lose a patient to suicide, but there is little training for how to cope with that event. Too many mental health professionals blame themselves when patient suicide occurs. There is a need to teach better coping mechanisms to deal with and better understand this event. The goal of the session is to increase understanding of suicide assessment. The session discusses how to deal with patient suicide as well as how to deal with family issues and possible litigation. : Harm to Self & Others, Practice Management : Benjamin J. Sadock, MD 5:45 P.M.–7:15 P.M. Putting Out the Fire: The Keys to Evidence- Based Effective Treatment of Panic Disorder The treatment of panic disorder is tremendously challenging and involves the proper use of psychotropic medications and appropriate psychotherapy based upon an understanding of the biopsychosocial etiology. The session teaches participants the keys to the evidence- based selection of these medications and the application of this psychotherapy. : Anxiety Disorders, Psychopharmacology : Stephen V. Sobel, MD Developing LGBT Sensitive Psychiatric Services Clinicians tend to have less experience and confidence treating lesbian, gay, bisexual, and transgender (LGBT) individuals in mainstream community mental health settings because this group is a minority in these settings. LGBT individuals tend to identify less with these settings, yet may have little choice but to receive treatment here for major psychiatric disorders. The session addresses these issues and provides practical guidelines for developing more inclusive treatment settings. : Practice Management, Treating the Whole Patient : Ronald E. Hellman, MD, MS, FAPA Wake Me Up Inside Suicide in our returning military members is at an all time high. In order to help the returning veterans from our recent wars and to decrease suicides, mental health professionals need to understand posttraumatic stress disorder from the patient’s perspective. For every one combat death this year, 25 service members will take their own life. The session discusses the barriers faced by patients and gives suggestions to providers to improve outcomes for our returning veterans and their families. : Posttraumatic Stress Disorder : Linda Stanley, PMHNP, MSHS, BSN WEDNESDAY, OCTOBER 2, 2013 “I’ve been attending Psych Congress for 8 years now, and I keep coming back because I get a feel for the changes in standards of practices. The updates on psychopharmacology, new medications, and psychotherapy intervention are invaluable for my practice.” — ARTURO R. HOUSTON, TX
  18. 18. REGISTER ONLINE! WWW.PSYCHCONGRESS.COM/PSYCHCONGRESS18 26TH ANNUAL 2013 ANNUAL PSY CH CONGR ESS THI N KING FORWA RD Scientific Program | THURSDAY, OCTOBER 3, 2013 8:00 A.M.–10:00 A.M. Industry Supported Symposia (CME) Breakfast will be served at 8:00 a.m. limited seating 8:30 A.M.–10:00 A.M. ADHD Across the Lifespan: An Update Attention-deficit hyperactivity disorder (ADHD) is one of the most common neurobehavioral disorders presenting for treatment in children and adolescents; and increasingly presenting for diagnosis and treatment in college-age students and adults. The session focuses on more recent understandings of ADHD and its treatment across the lifespan. Tracks: ADHD Speaker: Timothy E. Wilens, MD Cognitive-Behavioral Therapy for Psychosis The majority of patients treated for schizophrenia experience residual psychotic symptoms despite optimal pharmacotherapy. Cognitive-behavioral therapy (CBT) techniques for treating people with psychotic disorders are receiving renewed attention as an effective treatment strategy. The session educates mental health care professionals in the use of CBT for treating patients with psychotic symptoms. : Psychotherapy : Douglas L. Noordsy, MD 10:15 A.M.–11:45 A.M. Translating Neuroscience Discoveries to Clinical Practice There have been few truly transformative developments in psychiatric practice over the past four decades. New developments in the field of neuroscience are providing novel targets for treatment development and providing us new perspectives on the pathogenesis and treatment of neuropsychiatric disorders. The session presents background information on recent advances in the field of neuroscience and discusses how these findings can be used in the development of novel therapeutic strategies. : Neurology/Neuroscience, Psychopharmacology : Gerard Sanacora, MD, PhD The Concept Surrounding the Diagnosis and Treatments of Mixed States in Bipolar Disorder The goal of this session is to create an awareness that mixed states in bipolar disorder (BD) are the most common manifestation of BD and are associated with significant rates of mortality and psychosocial impairment. The goal of the session is also to educate mental health professionals on how to best recognize these mood states and effectively treat them. : Mood Disorders, Psychopharmacology : Vivek Singh, MD Successful Psychosocial Aging: Implications for Our Patients and Ourselves This session teaches participants about successful psychosocial aging in general as well as that in people with serious mental illness, specifically schizophrenia. The session discusses the definitions of successful aging as well as prevalence and predictors of self-rated successful aging in community-dwelling seniors. The session also explains the differences in trajectories of physical, cognitive, and psychosocial aging in people with schizophrenia as well as using appropriate pharmaceuticals and psychosocial treatment. : Geriatric Psychiatry : Dilip V. Jeste, MD 12:00 P.M.–2:00 P.M. Industry Supported Symposia (CME) Lunch will be served at 12:00 p.m. limited seating 12:30 P.M.–2:00 P.M. Collaborating With Primary Care Providers in Pain Patients Primary care providers are struggling with the evaluation and treatment of chronic pain patients. Primary care providers are not confident managing difficult pain patients. The psychosocial comorbidities in pain patients often dominate the persistent pain complaint: depression, anxiety, bipolar disorder, sleep disturbances, substance abuse, and others. Psychosocial services can develop a niche market to provide co-management skills to primary care on these patients. : Pain : Bill McCarberg, MD THURSDAY, OCTOBER 3, 2013
  19. 19. REGISTER EARLY AND SAVE! CALL 800-237-7285 EXT. 233 19 Scientific Program | 26TH ANNUAL 2013 ANNUAL PSY CH CONGR ESS THI N KING FORW A RD 2:15 P.M.–3:45 P.M. Pharmacologic Treatment of Borderline Personality Disorder: Agent Choice and Treatment Management This session reviews supporting data, which is often weak and contradictory, for the use of specific psychopharmacologic agents in borderline personality disorder. The session also makes recommendations on how to manage these patients and the prescribing process in order to minimize non-adherence, drug-drug interactions, and polypharmacy. : Personality Disorders, Psychopharmacology : Kenneth R. Silk, MD Optimizing the “Doc to Doc”: Managed Care Peer Reviewers Reveal What Clinicians Can Do, and What They Have a Right to Expect from Insurance Companies The session helps clinicians, especially those who work in inpatient and residential facilities, to be more successful when engaging in peer reviews. The presenters will strive to improve understanding of the review process and provide perspectives that can help clinicians be less frustrated and more satisfied with their effectiveness when engaging in these reviews on behalf of their patients. The presenters are experienced practitioners who now work as medical directors and conduct peer reviews for a large health care company. They will share concepts and frameworks that can help clinicians be better advocates for their patients who have managed care policies, and successfully negotiate within the framework of “medical necessity criteria” or “level of care guidelines” but beyond the most basic criteria of dangerousness or risk of harm. : Assessment & Adherence, Practice Management : Stuart Lustig, MD, MPH; Alvin R. Blank, MD Posttraumatic Stress Recovery: Biological and Psychotherapy Approaches Toward Healing Dilemmas of Loss, Spirit, and Meaning The session expands provider knowledge on various methods to assist in their work with psychiatric patients diagnosed with posttraumatic stress disorder (PTSD). The session discusses the use of integrative psychotherapy techniques that allow for a patient’s context to be taken into account, building rapport as a priority, and case examples of patient-centered approaches that focus on profound existential challenges, which often confront trauma survivors. The session also focuses briefly on current evidence-based medications that target PTSD symptoms. : Posttraumatic Stress Disorder, Psychotherapy : Lori Daniels, PhD, LCSW; James Boehnlein, MD 4:00 P.M.–5:30 P.M. Mental Health Clinicians’ Perspectives of Psychiatric Advance Directives Psychiatric Advance Directives (PADs) are legal documents that allow a person with a mental illness to communicate their preferences for future mental health treatment. Although many studies have shown a high demand for psychiatric advance directives, the use of PADs is limited. This session describes a descriptive study that examined mental health clinicians’ perceptions of PADs. : Ethics, Treating the Whole Patient : Judith Rice, DNP, PMHNP-BC, FNP-BC The Brain in Pain: How Headaches are Mental Health Issues and How to Help Headaches affect over 10% of the US population, mostly women, and has been estimated to be among the 10 most disabling conditions worldwide by the World Health Organization standards, with a massive 90% comorbidity with psychiatric disorders. Recent research suggests that there are common neuropathic mechanisms between these phenomena and bidirectional influences. The session aims to improve understanding of headache disorders, how they can complicate psychiatric issues, and how they can be treated. : Pain, Neurology/Neuroscience : Daniel Krashin, MD; Natalia Murinova, MD Leading-Edge Treatment Strategies for Pathological Gambling Pathological gambling impacts nearly 2% of the general population and is as common as schizophrenia or bipolar disorder. Most health care providers, even mental health specialists, do not receive formal training in the assessment and management of this powerful addictive disorder. The session summarizes and presents the latest scientific information about screening, diagnosis, treatment, and prevention of pathological gambling and related disorders. Emphasis will be placed on describing evidenced-based practices and how to translate efficacious clinical research findings into effective clinical treatment practices. : Substance Abuse, Addiction & Deterrence, Practice Management : Timothy Fong, MD THURSDAY, OCTOBER 3, 2013
  20. 20. REGISTER ONLINE! WWW.PSYCHCONGRESS.COM/PSYCHCONGRESS20 26TH ANNUAL 2013 ANNUAL PSY CH CONGR ESS THI N KING FORWA RD INTERACT The  Psych Congress   will feature the mostdynamicboothsandactivities,showcasingmorethan  prestigious exhibitors. Gain direct access to company representatives and learn how their products and services can benefit your patients. Find the latest offerings from academic book publishers, meet with pharmaceutical companies, speak with employee recruiters and receive valuable giveaways. EXPLORE The   showcases the latest research, innovative programs and topics in mental health. Take advantage of intimate peer-to-peer education and insightful discourse with presenters. Over  individual presentations on display and accessible over two days. Poster presentations are not intended or eligible for CME credit. Alcoholics Anonymous Alere Toxicology Alkermes, Inc. Alpha Health Systems American Physician Institute American Professional Agency, Inc. American Psychiatric Association American Psychiatric Publishing, Inc. Aspiro Adventure AssureRx Avanir Pharmaceuticals Clarity Way Compulink Business Systems, Inc. Cox Health The Delta Companies Eli Lilly and Company Forest Pharmaceuticals Genentech, a Member of the Roche Group Genomind The Gideons International Global Medical Staffing Gundersen Health System Independent Educational Consultants Assoc. Infinite Therapeutics International Bipolar Foundation Jackson & Coker Jazz Pharmaceuticals, Inc. Labrix Clinical Services, Inc. Lakemary Center Lippincott Williams & Wilkins Locumtenens.com Logistics Health Incorporated Medical Billing Professionals Medical Doctor Associates Metabolic Maintenance Ministry Health Care Natural Molecular Testing Corporation Neuronetics, Inc. NeuroScience, Inc. New Roads Treatment Center Northern Light Technologies Novartis Pharmaceuticals Corporation Omega Natural Science, Inc. Open Sky Wilderness Otsuka American Pharmaceuticals, Inc. Pamlab LLC (CerefolinNAC) Pamlab LLC (Deplin) Pfizer Professional Risk Management Services Psych Congress Network (Meet the Expert) RADMAX, LTD. Registry of Physician Specialists Southcentral Foundation Staff Care, Inc. Sunovion Pharmaceuticals Inc. Takeda Pharmaceuticals U.S.A., Inc. Teva Select Brands Valant Medical Solutions Validus Pharmaceuticals LLC Vista Points 2013 PSYCH CONGRESS EXHIBITORS* EXHIBIT HALL *Exhibit list as of may 1, 2013.
  21. 21. REGISTER EARLY AND SAVE! CALL 800-237-7285 EXT. 233 21 26TH ANNUAL 2013 ANNUAL PSY CH CONGR ESS THI N KING FORW A RD ENGAGE Take this opportunity to    as the  Psych Congress Advisory Board members engage in small-group question-and-answer sessions on topics that are critical to you, your patients and your practice. These intimate discussions will take place in the Psych Congress Network booth in the exhibit hall. Meet the Experts is not intended or eligible for CME credit. SUBMIT & WIN Don’t forget to submit your    entry form at the Psych Congress Network booth during exhibit hall hours each day to be entered to win exciting prizes. The grand prize winner will receive one free  Psych Congress registration, including airfare and hotel for four nights (a , value). September 30–October 3, 2013 | The Venetian, Las Vegas, NV
  22. 22. REGISTER ONLINE! WWW.PSYCHCONGRESS.COM/PSYCHCONGRESS22 26TH ANNUAL 2013 ANNUAL PSY CH CONGR ESS THI N KING FORWA RD Hotel The Venetian/The Palazzo 3355 Las Vegas Boulevard South Las Vegas, Nevada 89109 Reservations by phone: 877-385-3885 Online Reservations: http://bit.ly/15eHVne Reservations are now being accepted. A limited block of rooms is being held at The Venetian/The Palazzo for conference participants at a discounted rate of $209 USD plus tax per night for single or double occupancy. To receive the special conference rate, you must reserve by August 26, 2013 and reference group code RPMHE. Attendees are strongly encouraged to book their accommodations well ahead of the cut-off date to ensure space and rate availability. For ease of accessibility to the meeting space, all Psych Congress guest rooms are located in The Palazzo tower. When you arrive at the hotel, please indicate that you would like to be dropped off at The Palazzo entrance to ensure that you are in the closest proximity to your guest room. The room rate includes daily complimentary guest room internet for all Psych Congress attendees. At the time of check-in, attendees may choose to opt-in to the resort fee package for the additional cost of $20 USD plus tax per day. The resort fee includes unlimited local & toll free calls, daily newspaper per suite from hotel’s designated retail stores, access to Canyon Ranch fitness center for two adults, boarding pass printing, one regular coffee or tea at Café Presse, and two-for-one well drinks at any Venetian/Palazzo owned bar. Check-in/Check-out Check-in time is 3:00 p.m. Check out is 11:00 a.m. Cancellation Policy A deposit of one night’s room and tax is required at the time of booking. This deposit is non-refundable in the event of a cancellation. Airline and Transportation Information Airfare discounts for 2013 Psych Congress participants are available through various airlines. Book your flight by contacting: American Airlines www.AA.com 800-433-1790 Discount Code: 3193BG United Airlines www.United.com 800-468-7022 Discount Code: ZPJ3362058 Delta Airlines www.delta.com 800-328-1111 Discount Code: NMFM6 Car rental discounts for attendees are available through: Avis www.avis.com 800-331-1600 Discount Code: D016380 Super Shuttle offers shared ride van service as well as private sedan service at a 10% discount using show code HMPCM. Service can be booked in advance at www.supershuttle.com. HOTEL AND TRAVEL INFORMATION
  23. 23. REGISTER EARLY AND SAVE! CALL 800-237-7285 EXT. 233 23 ATTENDEE INFORMATION (Please print) ❒ Mr. ❒ Mrs. ❒ Ms. ❒ Male ❒ Female __________________________________________________________________________ First name MI Last name __________________________________________________________________________ Suffix/credentials (Jr., III, RN, MD, DPM, etc) __________________________________________________________________________ Name as it will appear on your badge including credentials (max 30 characters) Please note that commas and spaces are considered characters. __________________________________________________________________________ Title __________________________________________________________________________ Department Institution name Position __________________________________________________________________________ Address 1 __________________________________________________________________________ Address 2 __________________________________________________________________________ City State Zip Country __________________________________________________________________________ Telephone Fax __________________________________________________________________________ Email address (confirmations will be sent via e-mail) PROFESSIONAL INFORMATION Graduation Year_________ Position____________________ Profession: ❒ Physician ❒ Nurse ❒ Nurse practitioner ❒ Physician assistant ❒ Psychologist ❒ Counselor ❒ Pharmacist ❒ Social worker ❒ Other Practice setting 1 (required): ❒ Academic ❒ Group practice (2–5 clinicians) ❒ Group practice (6–9 clinicians) ❒ Group practice (10+ clinicians) ❒ Private practice ❒ HMO ❒ Community hospital/facility ❒ Private hospital/facility ❒ VA/federal hospital/facility ❒ State hospital/facility ❒ Other Primary Specialty (required): ❒ Psychiatry ❒ General Practice ❒ Family Practice ❒ Internal Medicine ❒ Neurology ❒ Psychology ❒ Other: _____________________________ How many patients do you see on a weekly basis? ❒ 10 or fewer ❒ 11-29 ❒ 30-39 ❒ 40-49 ❒ 50 or more PRE-CONFERENCE REGISTRATION ❒ I will attend the 2013 Psych Congress pre-conference educational sessions from 2:30 p.m.-4:00 p.m. on Sunday, September 29 (no additional charge). ❒ I wish to attend the 2013 Psych Congress keynote dinner on Sunday, September 29 from 4:30 p.m.-7:00 p.m. if seating is available (no additional charge). Seating is limited. Please check your registration confirmation to confirm your seat. SYLLABUS PURCHASE ❒ 2013 Psych Congress printed syllabus ($100 before September 28, 2013; $150 on-site) You get two bound volumes of printed comprehensive session handouts — ideal for note-taking during the sessions and a handy reference tool after Psych Congress concludes — at badge pickup. ❒ 2013 Psych Congress flash drive syllabus ($50 before September 28, 2013; $75 on-site) You get a credit card-sized USB drive containing all session handouts.You can access them anywhere, anytime — view on screen, or print for note-taking. Retrievable at badge pickup. CANCELLATION POLICY Cancellation requests postmarked by Friday,August 30, 2013 will be honored in the form of a full refund, minus a $100 processing fee. No refunds will be issued after August 30, 2013. If you do not cancel or do not attend you are still responsible for full payment. There are no exceptions to these policies. Payments made may not be applied to tuition for future Psych Congress events, nor other meetings or products offered by NACCME LLC. For full details, visit www.psychcongress.com. METHOD OF PAYMENT Choose from the following options: ❒ Check payable to HMP Communications. All checks must be drawn on a U.S. bank in U.S. funds. Mail to 83 General Warren Blvd., Suite 100; Malvern, PA 19355. Credit Card (check one) ❒ MasterCard ❒ Visa ❒ American Express Name on card ______________________________________Billing post code _____________ Credit card No. _______________________________________________________________ Expiration date _________________________________ Security code ___________________ __________________________________________________________________________ Signature of cardholder (required) FAX COMPLETED FORM TO 610-560-0502. 2013 ATTENDEE RATES • May 13–June 13 $649 • June 14–August 22 $699 • August 23–September 22 $799 • On-site $1,099 PSYCH CONGRESS REGISTRATION THREE EASY WAYS TO REGISTER: 1. Complete registration at www.psychcongress.com/psychcongress 2. Call 800-237-7285, ext. 233, and have your credit card information handy. 3. Fill out and fax the enclosed registration form to 610-560-0502.
  24. 24. 83GeneralWarrenBlvd. Suite100 Malvern,PA19355 www.hmpcommunications.com LLC, ™ ® 26THANNUAL 2013 ANNUAL PSY CH CONGR ESS THI N KINGFORW A RD Sept30–Oct3,2013 THEVENETIAN,LASVEGAS,NV 26THANNUAL 2013 ANNUAL PSY CH CONGR ESS THI N KINGFORW A RD SCIENTIFICPROGRAM COMPLETESCHEDULE REGISTEREARLYAND SAVEUPTO$400 September30–October3,2013 THEVENETIAN,LASVEGAS,NV 800-237-7285EXT.233 PSYCHCONGRESS.COM/PSYCHCONGRESS 90+Exhibitors&Sponsors 50+ExcitingSessions Upto30CME/CECredits ® THREEEASYWAYSTOREGISTER: 1Completeregistrationat psychcongress.com/psychcongress 2Call800-237-7285,ext.233, andhaveyourcreditcard informationhandy. 3Filloutandfaxtheenclosed registrationformto610-560-0502. REGISTERBYAUGUST22 FORONLY$699.

×